Only 1 Number Mattered in Arena Pharmaceuticals' Q3 Results -- and It Was Big
Some biotech stocks might be struggling in 2019, but not Arena Pharmaceuticals (NASDAQ: ARNA). Its share price is up over 20% so far this year. However, that's a lot less than this summer when Arena's shares were up more than 60%.
Arena announced its third-quarter results after the market closed on Thursday. Don't expect the biotech's news to kick off a dramatic rebound, but a major slide isn't likely, either. There was really only one number that mattered in Arena's Q3 results -- and it was a big one.
Image Source: Getty Images.
Source Fool.com
